Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al
| Bristol-Myers Squibb Co. and E. R. Squibb & Sons, L.L.C. |
| AstraZeneca Pharmaceuticals LP and AstraZeneca AB |
| 1:2023cv00079 |
| January 23, 2023 |
| US District Court for the District of Delaware |
| Matthew F Kennelly |
| Patent |
| 35 U.S.C. § 271 Patent Infringement |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 13, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney David I. Berl, Jessamyn S. Berniker, Jessica L. Pahl, Jessica Palmer Ryen, Kevin Hoagland-Hanson, Lydia B Cash, Seth R. Bowers, and Thomas S. Fletcher for AstraZeneca AB and AstraZeneca Pharmaceuticals LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Pro Hac Vice Attorney Rachel J. Elsby,Matthew H. Hartman,Steven D. Maslowski,Karina J. Moy,Svetlana Pavlovic for Bristol-Myers Squibb Co.,and E. R. Squibb & Sons, L.L.C. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Filing 14 NOTICE of Appearance by Matthew Alan Pearson on behalf of Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C. (Pearson, Matthew) |
| Filing 13 ANSWER to #7 Answer to Complaint, Counterclaim by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C..(Farnan, Michael) |
Filing 12
SO ORDERED D.I. #10 MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Thomas S. Fletcher, Jessamyn S. Berniker, Jessica L. Pahl, Kevin D. Hoagland-Hanson, Jessica Palmer Ryen, Seth R. Bowers, Lydia B. Cash filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB and D.I. #11 MOTION for Pro Hac Vice Appearance of Attorney Steven D. Maslowski, Matthew H. Hartman, Karina J. Moy, Rachel J. Elsby and Svetlana Pavlovic filed by E. R. Squibb & Sons, L.L.C., Bristol-Myers Squibb Co. Ordered by Judge Matthew F Kennelly on 03/08/2023. (smg)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Steven D. Maslowski, Matthew H. Hartman, Karina J. Moy, Rachel J. Elsby and Svetlana Pavlovic - filed by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C.. (Farnan, Brian) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Thomas S. Fletcher, Jessamyn S. Berniker, Jessica L. Pahl, Kevin D. Hoagland-Hanson, Jessica Palmer Ryen, Seth R. Bowers, Lydia B. Cash - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Certifications for David I. Berl, Thomas S. Fletcher, Jessamyn S. Berniker, Jessica L. Pahl, Kevin D. Hoagland-Hanson, Jessica Palmer Ryen, Seth R. Bowers, Lydia B. Cash)(Joyce, Alexandra) |
| Filing 9 NOTICE of Appearance by Alexandra M. Joyce on behalf of AstraZeneca AB, AstraZeneca Pharmaceuticals LP (Joyce, Alexandra) |
| Filing 8 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB, AstraZeneca Pharmaceuticals LP filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Filing 7 ANSWER to #1 Complaint, with Jury Demand , COUNTERCLAIM against Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C. by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Filing 6 SUMMONS Returned Executed by E. R. Squibb & Sons, L.L.C., Bristol-Myers Squibb Co..AstraZeneca Pharmaceuticals LP served on 1/25/2023, answer due 2/15/2023. (Farnan, Michael) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bristol-Myers Squibb Co. for E. R. Squibb & Sons, L.L.C. filed by Bristol-Myers Squibb Co., E. R. Squibb & Sons, L.L.C.. (Farnan, Michael) |
| Case Assigned to Judge Matthew F Kennelly of the United States District Court for the Northern District of Illinois (due to related case 22-cv-346-MFK). Please include the initials of the Judge (MFK) after the case number on all documents filed. (rjb) |
| Filing 4 Summons Issued as to AstraZeneca Pharmaceuticals LP on 1/24/2023. (twk) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,320,811 B2; US 9,273,135 B2. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed with Jury Demand against AstraZeneca AB, AstraZeneca Pharmaceuticals LP ( Filing fee $ 402, receipt number ADEDC-4050282.) - filed by E. R. Squibb & Sons, L.L.C., Bristol-Myers Squibb Co. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Civil Cover Sheet)(twk) |
| DEFICIENCY NOTICE issued by the Court to Plaintiff: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
